Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
217.80    -2.40 (-1.09%)
Bid:
217.40
Ask:
218.00
Spread: 0.60 (0.276%)
Market Cap: £953.40m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Board Appointment

7 Sep 2020 07:00

RNS Number : 1465Y
Kier Group PLC
07 September 2020
 

Kier Group plc

Board Appointment

Kier Group plc (the "Company" or the "Group") announces the appointment of Alison Atkinson to its board of directors (the "Board"). The appointment will take effect on 15 December 2020.

Alison Atkinson is the Chief Executive Officer of AWE plc ("AWE"). A civil engineer by background, Alison joined AWE in 2005, having previously worked for Halcrow Group as an engineer and a project manager. Alison has held a number of senior operational roles at AWE, including Executive Director, Infrastructure Projects Delivery from 2016 to 2020. Alison was appointed as AWE's Chief Executive Officer in May 2020.

Alison will be the Chair of the Safety, Health and Environment Committee (the "SHE Committee") and a member of the Nomination Committee, the Remuneration Committee and the Risk Management and Audit Committee.

Matthew Lester, Chairman, said: "We are delighted that Alison will be joining the Board. The Board will benefit from Alison's depth of experience on operational matters and, as the Chair of the SHE Committee, Alison will oversee the Group's increasing focus on sustainability matters. I look forward to working with Alison."

No information is required to be disclosed pursuant to Listing Rule 9.6.13R.

Further information

Please contact:

 

 

Kier Press Office 

+44 (0)1767 355 096

Richard Mountain/Nick Hasell - FTI Consulting 

+44 (0)20 3727 1340

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 and the Company's results announcement for the six months ended 31 December 2019 for further information about the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUNVBRRBUKRRR
Date   Source Headline
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:45 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:33 amRNSTransaction in Own Shares
21st Jan 20252:11 pmRNSDirector/PDMR Shareholding
21st Jan 20257:01 amRNSLaunch of £20m share buyback programme
21st Jan 20257:00 amRNSTrading Update
2nd Jan 202511:05 amRNSBlock listing Interim Review
20th Dec 202411:20 amRNSDirector/PDMR Shareholding
13th Dec 20241:11 pmRNSDirector/PDMR Shareholding
10th Dec 20243:34 pmRNSDirector/PDMR Shareholding
6th Dec 202410:37 amRNSHolding(s) in Company
5th Dec 20249:14 amRNSNotification of Change of Director Details
4th Dec 20244:43 pmRNSDirector/PDMR Shareholding
2nd Dec 20242:39 pmRNSTotal Voting Rights
20th Nov 20244:03 pmRNSDirector/PDMR Shareholding
18th Nov 202411:47 amRNSHolding(s) in Company
14th Nov 20242:45 pmRNSResult of AGM
14th Nov 20247:00 amRNSAGM Trading Update
13th Nov 20242:58 pmRNSHolding(s) in Company
8th Nov 202410:36 amRNSDirector/PDMR Shareholding
4th Nov 20245:28 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20243:21 pmRNSDirector/PDMR Shareholding
29th Oct 202411:26 amRNSBlock Listing Application
22nd Oct 202412:47 pmRNSDirector/PDMR Shareholding
16th Oct 20244:23 pmRNSAnnual Financial Report Amendment
14th Oct 20242:53 pmRNSDirector/PDMR Shareholding
4th Oct 202412:00 pmRNSAnnual Financial Report
1st Oct 202412:09 pmRNSTotal Voting Rights
23rd Sep 20242:03 pmRNSHolding(s) in Company
23rd Sep 202410:21 amRNSDirector/PDMR Shareholding
12th Sep 20247:05 amRNSDirectorate Change
12th Sep 20247:00 amRNSFY24 Results
6th Sep 20242:29 pmRNSHolding(s) in Company
2nd Sep 202412:33 pmRNSTotal Voting Rights
22nd Aug 20241:51 pmRNSDirector/PDMR Shareholding
12th Aug 20245:32 pmRNSNotice of Results and Presentations
1st Aug 20249:59 amRNSTotal Voting Rights
18th Jul 20247:00 amRNSFull Year 2024 Trading Update
16th Jul 20243:38 pmRNSHolding(s) in Company
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:28 amRNSTotal Voting Rights
28th Jun 20244:34 pmRNSDirector/PDMR Shareholding
27th Jun 20244:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.